✦ LIBER ✦

Cloning of the TIS gene suppressed by topoisomerase inhibitors

✍ Scribed by Yoshiaki Onishi; Sadamitsu Hashimoto; Harutoshi Kizaki

Book ID: 117523217
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 432 KB
Volume: 215
Category: Article
ISSN: 0378-1119
DOI: 10.1016/s0378-1119(98)00313-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Molecular Cloning of the Genes Suppresse

Molecular Cloning of the Genes Suppressed in RVC Lymphoma Cells by Topoisomerase Inhibitors

✍ Yoshiaki Onishi; Harutoshi Kizaki 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 270 KB

Cloning and characterization of the rat

Cloning and characterization of the rat TIS11 gene

✍ Norio Kaneda; Tomiyasu Murata; Yoshiro Niimi; Makoto Minamiyama 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 346 KB

Cloning and characterization of the Aspe

Cloning and characterization of the Aspergillus nidulans DNA topoisomerase I gene

✍ Rukiyah T Van Dross; Kamakshi V Rao; Eric Eisenberg; Marilyn M Sanders 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Cloning and characterization of the gene

Cloning and characterization of the gene encoding Trypanosoma cruzi DNA topoisomerase II

✍ Stenio P. Fragoso; Samuel Goldenberg 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 700 KB

Cloning and characterization of the gene

Cloning and characterization of the gene encoding Aspergillus nidulans DNA topoisomerase II

✍ Kil-Hwan Kim; Tomohiro Akashi; Ikuyo Mizuguchi; Akihiko Kikuchi 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 551 KB

Hypersensitivity of NIH3T3 cells transfo

Hypersensitivity of NIH3T3 cells transformed by H-RAS gene to DNA-topoisomerase-I inhibitors

✍ Tatsuo Ohira; Kazuto Nishio; Fumihiko Kanzawa; Tomoyuki Ishida; Yuichiro Ohe; Hi 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 736 KB

We examined the effects of the introduction of H-ras oncogene into murine cell line NIH3T3 on growth inhibition by topoisomerase-I (topo-I) inhibitors. The H-ras-transformed cells (pT22-3) showed approximately I 2-fold increased sensitivity to a novel topo-l inhibitor, NB-506 [6-N-formylamino-I2,I3d